March 17, 2017

Group’s Transparency Proposals for FDA Include Release of Trial Data

A Blueprint for Transparency at the FDA, which was published online March 13 by JAMA, includes several recommendations involving clinical trial data.

The Blueprint was developed by an academic working group with members from Johns Hopkins, Har...

You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.

Feedback Form
Leads to Insight